GLAXOSMITHKLINE PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of GlaxoSmithKline Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.19₹ 4.85
As on Oct 31, 2025, 4:01 PM IST
GlaxoSmithKline Pharmaceuticals Price Performance
Today's LowToday's High
₹2,612.05₹2,698.00
₹2,624.25
52 Weeks' Low52 Weeks' High
₹1,924.30₹3,515.95
₹2,624.25
Open Price
₹2,627.45
Prev. Close
₹2,619.40
Volume
2,037
Over the last 5 years, the share price of GlaxoSmithKline Pharmaceuticals has gained 13.24% CAGR. Over the past year, the corresponding return has been -3.51%.
GlaxoSmithKline Pharmaceuticals’s current P/E of 46.78x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
GlaxoSmithKline Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
| Cohance Lifesciences | -14.14 | -13.44 | -24.49 | -33.68 | -42.74 | 23.71 | 20.22 |
Over the last one year, GlaxoSmithKline Pharmaceuticals has declined 3.51% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, GlaxoSmithKline Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,723.16 | 2,662.83 |
| 10 | 2,733.08 | 2,691.66 |
| 20 | 2,727.63 | 2,714.35 |
| 50 | 2,757.01 | 2,770.9 |
| 100 | 2,960.47 | 2,824.42 |
| 200 | 2,781.7 | 2,782.5 |
GlaxoSmithKline Pharmaceuticals Share Holding Pattern
In the latest quarter, GlaxoSmithKline Pharmaceuticals saw a rise in promoter holding to 150.00%, while DII stake increased to 8.00%, FII holding rose to 5.00%, and public shareholding moved down to 12.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
GlaxoSmithKline Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 12,00,000 | 1.44 | 319.16 | |
| 11,00,000 | 1.03 | 292.57 | |
| 9,13,226 | 2.99 | 242.89 | |
| 5,59,000 | 0.38 | 148.68 | |
| 5,32,312 | 0.93 | 141.58 | |
| 3,99,331 | 0.2 | 106.21 | |
| 2,60,835 | 1.88 | 69.37 | |
| 2,20,000 | 0.84 | 58.51 | |
| 1,74,606 | 0.82 | 46.44 | |
| 1,50,000 | 1.82 | 39.9 |
* Excluding Index & Arbitrage Funds
GlaxoSmithKline Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 30, 2025, 10:15 PM IST | GlaxoSmithKline Phar - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 29, 2025, 6:17 AM IST | GlaxoSmithKline Phar - Announcement under Regulation 30 (LODR)-Change in Management |
| Oct 27, 2025, 7:56 PM IST | GlaxoSmithKline Phar - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter & Half Year Ende |
| Oct 08, 2025, 5:57 AM IST | GlaxoSmithKline Phar - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 08, 2025, 11:02 PM IST | GlaxoSmithKline Phar - Disclosure Under Regulation 30 |
About GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1924PLC001151 and registration number is 001151. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 3723.49 Cr. and Equity Capital is Rs. 169.41 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressGSK House, Dr. Annie Besant Road, Mumbai Maharashtra 400030
- Contact
Management
- Ms. R S KarnadChairperson
- Mr. B AkshikarManaging Director
- Mr. J ChandyWholeTime Director & CFO
- Mr. S WilliamsNon Executive Director
- Mr. M AnandIndependent Director
- Mr. P R SomasundaramIndependent Director
- Dr. A WadhawanIndependent Director
- Dr.(Ms.) S MaheshwariIndependent Director
FAQs on GlaxoSmithKline Pharmaceuticals Share Price
What is the share price of GlaxoSmithKline Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for GlaxoSmithKline Pharmaceuticals is ₹2,624.25 as on Oct 31, 2025.
What kind of stock is GlaxoSmithKline Pharmaceuticals?
The GlaxoSmithKline Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of GlaxoSmithKline Pharmaceuticals?
The market cap of GlaxoSmithKline Pharmaceuticals is ₹44,456.38 Cr as on Oct 31, 2025.
What are today's High and Low prices of GlaxoSmithKline Pharmaceuticals?
Today’s highest and lowest price of GlaxoSmithKline Pharmaceuticals are ₹2,698.00 and ₹2,612.05.
What are the 52 Week High and 52 Week Low of GlaxoSmithKline Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which GlaxoSmithKline Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of GlaxoSmithKline Pharmaceuticals is ₹3,515.95 and 52-week low of GlaxoSmithKline Pharmaceuticals is ₹1,924.30 as on Oct 31, 2025.
How has the GlaxoSmithKline Pharmaceuticals performed historically in terms of returns?
The GlaxoSmithKline Pharmaceuticals has shown returns of 0.19% over the past day, -2.61% for the past month, -16.91% over 3 months, -3.51% over 1 year, 23.97% across 3 years, and 13.24% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of GlaxoSmithKline Pharmaceuticals?
P/E ratio of and PB ratio of GlaxoSmithKline Pharmaceuticals are 46.78 and 22.78 on Oct 31, 2025. While the company gives a dividend yield of 2.06 per annum.
GlaxoSmithKline Pharmaceuticals News
✕
Market Pulse